Company Monitoring Page for Sandoz

job ratings for Sandoz

06/29/23
industry:
Biotech
company:
Sandoz
job rating:
4
Boss is not trustworthy.

latest headlines for company on cafepharma

Sandoz shells out $275M in latest effort to move past 'legacy' price-fixing litigation
Fierce Pharma
Tue, 12/17/24 - 12:03 pm
Tags:
Sandoz, price fixing, legal
Sandoz, Liquidia score $137M win against United in years-long generic Remodulin dispute
Fierce Pharma
Mon, 09/16/24 - 10:22 pm
Tags:
Sandoz, United Therapeutics, generics, PAH, Treprostinil
As Sandoz contract winds down, GSK will close antibiotics plant in UK
Fierce Pharma
Mon, 09/9/24 - 07:18 pm
Tags:
GSK, Sandoz, UK, drug manufacturing
Sandoz lifts guidance after Humira biosimilar drives another quarter of sales growth
Fierce Pharma
Fri, 08/9/24 - 11:25 am
Tags:
Sandoz, earnings, biosimilars, Humira, AbbVie, Novartis
Sandoz delivers 6% sales growth with Humira biosimilar leading the charge
Fierce Pharma
Tue, 05/7/24 - 06:30 pm
Tags:
Sandoz, earnings, biosimilars, AbbVie, Humira
CVS Caremark’s Policy Shift On Humira Biosimilars May Not Be What The Doctor Ordered
Forbes
Thu, 05/2/24 - 11:34 am
Tags:
CVS Caremark, AbbVie, Humira, biosimilars, Hyrimoz, Sandoz, PBMs
Sandoz Nabs FDA Approvals for First Two Biosimilars for Amgen’s Denosumab
BioSpace
Wed, 03/6/24 - 11:29 am
Tags:
Sandoz, biosimilars, FDA, Amgen, denosumab, Prolia, Jubbonti, Xgeva, Wyost
Sandoz completes acquisition of ranibizumab biosimilar
Healio
Mon, 03/4/24 - 11:52 pm
Tags:
Sandoz, ranibizumab, Coherus Biosciences, Cimerli
Sandoz will pay $265m to settle price fixing case in US
Pharmaphorum
Thu, 02/29/24 - 09:44 am
Tags:
Sandoz, price fixing, legal, Pennsylvania
Amid tough generics market, Sandoz to lay off 213 and shutter Eon Labs plant in North Carolina
Fierce Pharma
Thu, 02/8/24 - 09:57 pm
Tags:
Sandoz, layoffs, North Carolina, generics, drug manufacturing
Sandoz makes its first post-spinout acquisition
Pharmaphorum
Mon, 01/22/24 - 11:12 am
Tags:
Sandoz, M&A, Coherus, biosimilars
AbbVie flexes litigation muscle with Rinvoq patent lawsuit against Sandoz, other generic players
Fierce Pharma
Wed, 11/22/23 - 11:39 am
Tags:
AbbVie, Rinvoq, patents, legal, Sandoz, Sun Pharma, Intas Pharmaceuticals
Novartis' Sandoz dips on debut after lower than expected valuation
Reuters
Wed, 10/4/23 - 09:43 am
Tags:
Novartis, Sandoz, spinoffs
Novartis confirms Sandoz spin-off for October 4, 2023
Reuters
Mon, 09/25/23 - 07:45 pm
Tags:
Novartis, Sandoz, spinoffs
Sandoz to Commercialize Samsung Bioepis’ Biosimilar to J&J’s Stelara
BioSpace
Tue, 09/12/23 - 10:40 am
Tags:
Sandoz, Samsung Bioepis, biosimilars, JNJ, Stelara
Novartis updates on Sandoz finances ahead of spin-off
Pharmaphorum
Tue, 09/5/23 - 11:18 am
Tags:
Novartis, Sandoz, spinoffs, generics, biosimilars
FDA Decisions 2023: Sandoz, Gilead Sciences and More
BioSpace
Fri, 08/25/23 - 11:31 am
Tags:
FDA, Sandoz, Novartis, Gilead Sciences, Pfizer, Neurocrine, Regeneron, Ipsen, Revance Therapeutics, Delcath Systems, Janssen, Galera Therapeutics, Biogen, Roche, Mesoblast, Taiho Oncology
FDA Approves Sandoz Biosimilar to Biogen’s MS Therapy Tysabri
BioSpace
Fri, 08/25/23 - 09:53 am
Tags:
Biogen, Sandoz, FDA, biosimilars, MS, multiple sclerosis, Tysabri
Novartis cites strong sales growth for $15B Sandoz spin-off as board vote unanimously for separation
Biopharma Reporter
Mon, 08/21/23 - 06:50 pm
Tags:
Novartis, Sandoz, spinoff, biosimilars, generics
Novartis floats share distribution scheme as it plots Sandoz spinoff for Oct. 4
Fierce Pharma
Fri, 08/18/23 - 11:29 am
Tags:
Novartis, Sandoz, spinoffs, generics, biosimilars

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.